PPA
CLCD

Parametric Portfolio Associates’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Parametric Portfolio Associates’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-14,587
Closed -$531K – 3867
2016
Q4 		$531K Sell
14,587
-23,025
-61% -$815K ﹤0.01% 3157
2016
Q3 		$1.44M Buy
+37,612
New +$556K ﹤0.01% 2584

Other funds holding CLCD

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Parametric Portfolio Associates's CLCD Position: Q1 2017 in Review

Parametric Portfolio Associates sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 14,587 shares — an estimated $531K sold.

Parametric Portfolio Associates first reported a position in CLCD in Q3 2016 and held it in 2 quarters. The position peaked at $1.44M in Q3 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

  • Parametric Portfolio Associates reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Parametric Portfolio Associates sold 14,587 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $531K.
  • Parametric Portfolio Associates first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
  • Parametric Portfolio Associates's CoLucid Pharmaceuticals, Inc. position peaked at $1.44M in Q3 2016.
  • 1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Parametric Portfolio Associates's 13F filing for Q1 2017, filed 8 May 2017.